Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
Hannah Alison L. received 24,400 Rigel Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jul 8, 2026 · Filed Jul 10, 2026
On Jul 8, 2026, Hannah Alison L. (EVP, Chief Medical Officer) received 24,400 Rigel Pharmaceuticals, Inc. shares as an award, leaving 35,025 shares. Filed Jul 10, 2026 (Form 4).
- Awarded
- 24,400 shares
- Holding after
- 35,025 shares
- Trading plan
- No
- Role
- EVP, Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | Award | 24,400 | 35,025 | Direct |
Source
Related
- Rigel Pharmaceuticals, Inc.
- Hannah Alison L.
- Rigel Pharmaceuticals, Inc. shareholders
- Form 4 · Hannah Alison L. · May 19, 2026
- Form 4 · Schorno Dean L · Sep 3, 2026
- Form 4 · Santos David A · Sep 3, 2026
- Form 4 · Rodriguez Raul R · Sep 3, 2026
- Form 4 · Furey Raymond J. · Sep 3, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026